Morpholino

MO5-nr3c1

ID
ZDB-MRPHLNO-120313-2
Name
MO5-nr3c1
Previous Names
None
Target
Sequence
5' - CTCCAGTCCTCCTTGATCCATTTTG - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genome Build: GRCz11Chromosome: 14
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO5-nr3c1
No data available
Phenotype
Phenotype resulting from MO5-nr3c1
Phenotype Fish Figures
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal WT + MO5-nr3c1 Fig. 6,  Fig. 7 from Kwan et al., 2016
1 - 1 of 1
Phenotype of all Fish created by or utilizing MO5-nr3c1
Phenotype Fish Conditions Figures
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal WT + MO5-nr3c1 chemical treatment by environment: cortisol Fig. 6 from Kwan et al., 2016
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal WT + MO5-nr3c1 chemical treatment by environment: serotonin Fig. 6 from Kwan et al., 2016
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal WT + MO5-nr3c1 control Fig. 6,  Fig. 7 from Kwan et al., 2016
ventral wall of dorsal aorta hematopoietic multipotent progenitor cell runx1 expression decreased amount, abnormal WT + MO5-nr3c1 chemical treatment by environment: cobalt dichloride Fig. 7 from Kwan et al., 2016
hematopoietic multipotent progenitor cell decreased amount, abnormal pd27Tg; zf169Tg + MO5-nr3c1 control Fig. 6,  Fig. 7 from Kwan et al., 2016
1 - 5 of 8 Show all
Citations
TSV
1 - 6 of 6
Show
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.